D. C. McLachlan

发表

Effect of exposure of miners to aluminium powder

P. Corey, S. Rifat, M. Eastwood, 1990, The Lancet.

Desferrioxamine for Alzheimer's disease

P. Davies, R. Garruto, T. Kruck, 1991, The Lancet.

Suppression of deferoxamine mesylate treatment — induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation

T. Kruck, D. C. McLachlan, E. A. Fisher, 1990, Clinical pharmacology and therapeutics.

Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165

P. S. St George-Hyslop, D. Dickson, B. Ghetti, 1995, Journal of neuropathology and experimental neurology.

Alzheimer’s Disease: Errors in Gene Expression

D. C. McLachlan, P.N. Lewis, 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Oat phenolics : avenalumic acids, a new group of bound phenolic acids from oat groats and hulls

B. Blackwell, F. Collins, D. C. McLachlan, 1991 .

A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate

T. Kruck, D. C. McLachlan, E. A. Fisher, 1993, Clinical pharmacology and therapeutics.

Alzheimer's disease and possible gene interaction.

D. Pollen, J. Haines, M. Pericak-Vance, 1994, Science.

HERPES-SIMPLEX VIRAL GENOME AND SENILE AND PRESENILE DEMENTIAS OF ALZHEIMER AND PICK

M. Petrič, N. B. Rewcastle, P. Middleton, 1980, The Lancet.

Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate

U. Boni, D. C. McLachlan, 1985, Journal of the Neurological Sciences.

Run-on gene transcription in human neocortical nuclei

N. Bazan, W. Lukiw, L. Carver, 1998, Journal of Molecular Neuroscience.

An informative microsatellite repeat polymorphism in the human neurofilament light polypeptide (NEFL) gene.

P. S. St George-Hyslop, E. Rogaeva, G. Vaula, 1992, Human molecular genetics.